Identifying novel breast cancer subtypes effect on clinical response to neoadjuvant chemotherapy

被引:0
|
作者
Bhatt, N. [1 ]
Fiuza-Castinieria, C. [1 ]
Murphy, S. [1 ]
O'Connor, M. [1 ]
O'Donoghue, G. T. [1 ]
机构
[1] Waterford Reg Hosp, Waterford, Ireland
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:22 / 22
页数:1
相关论文
共 50 条
  • [41] Relevance of breast cancer subtypes for magnetic resonance imaging response monitoring during neoadjuvant chemotherapy
    Gomez-Raposo, Cesar
    Andreu, Monica
    Suarez-Garcia, Ines
    Isabel Esteban, M.
    Carballo, Mar
    Sereno-Moyano, Maria F.
    Vazquez Osorio, Jose L.
    Heras, Javier
    Zambrana Tevar, Francisco
    Pelayo, Eva
    Lopez-Gomez, Miriam
    Garcia de Santiago, Clara
    Merino Salvador, Maria
    Casado, Enrique
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (06): : 486 - 488
  • [42] PARP is expressed in all subtypes of early breast cancer and is a predictive factor for response to neoadjuvant chemotherapy
    von Minckwitz, G.
    Mueller, B.
    Loibl, S.
    Blohmer, J. U.
    duBois, A.
    Huober, J.
    Kandolf, R.
    Budczies, J.
    Denkert, C.
    EJC SUPPLEMENTS, 2010, 8 (03): : 188 - 188
  • [43] Predictive Role of Molecular Subtypes in Response to Neoadjuvant Chemotherapy in Breast Cancer Patients in Northeast China
    Lv, Minhao
    Li, Beibei
    Li, Yongfeng
    Mao, Xiaoyun
    Yao, Fan
    Jin, Feng
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (09) : 2411 - 2417
  • [44] Pathologic response pattern of breast cancer after neoadjuvant chemotherapy: its correlation with molecular subtypes
    Song, In-Hye
    Lee, Hee Jin
    Gong, Gyungyub
    CANCER RESEARCH, 2014, 74 (19)
  • [45] Prediction of neoadjuvant chemotherapy response in breast cancer
    Izquierdo, M.
    Rodriguez, I.
    Tresserra, F.
    Maria, G.
    Baulies, S.
    Ara, C.
    Fabregas, R.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S95 - S95
  • [46] Prediction of neoadjuvant chemotherapy response in breast cancer
    Izquierdo, M.
    Rodriguez, I.
    Tresserra, F.
    Baulies, S.
    Ara, C.
    Fabregas, R.
    BREAST, 2017, 32 : S79 - S79
  • [47] Response to neoadjuvant chemotherapy in HER2 non-overexpressing breast cancer subtypes
    Ilie, S. M.
    Desmoulins, I.
    Hennequin, A.
    Coureche-Guillaume, K.
    Arnould, L.
    Nathalie, B.
    Bertaut, A.
    Ladoire, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [48] PREDICTION OF NEOADJUVANT CHEMOTHERAPY RESPONSE IN BREAST CANCER
    Myllys, Maiju
    EXCLI JOURNAL, 2021, 20 : 625 - 627
  • [49] Race, Response to Chemotherapy, and Outcome within Clinical Breast Cancer Subtypes.
    Tichy, J. R.
    Deal, A. M.
    Anders, C. K.
    Carey, L. A.
    CANCER RESEARCH, 2011, 71
  • [50] Androgen Receptor Expression in an Indian Breast Cancer Cohort with Relation to Molecular Subtypes and Response to Neoadjuvant Chemotherapy - Prospective Clinical Study
    Anand, Akshay
    Singh, Kul R.
    Kumar, Surender
    Husain, Nuzhat
    Kushwaha, Jitendra K.
    Sonkar, Abhinav A.
    BREAST CARE, 2017, 12 (03) : 160 - 164